These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3497148)

  • 1. Structure-activity relations of 4-fluoromethyl monobactams.
    Matsuda K; Nakagawa S; Nakano F; Inoue M; Mitsuhashi S
    J Antimicrob Chemother; 1987 Jun; 19(6):753-60. PubMed ID: 3497148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential hydrolysis of cis configuration compounds at the 3,4 position of monobactams by beta-lactamase from Morganella morganii.
    Matsuda K; Sanada M; Nakagawa S; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1991 Mar; 35(3):458-61. PubMed ID: 2039196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial activity of tigemonam dicholate (SQ 30836) and interaction with beta-lactamases of gram-negative bacteria.
    Raimondi A; Cocuzza CE
    J Chemother; 1989 May; 1 Suppl 2():13-21. PubMed ID: 2809698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure activity relationships among the monobactams.
    Bonner DP; Sykes RB
    J Antimicrob Chemother; 1984 Oct; 14(4):313-27. PubMed ID: 6389473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro antibacterial activity of BO-1165, a new monobactam antibiotic.
    Matsuda K; Nagashima M; Nakagawa S; Inoue M; Mitsuhashi S
    J Antimicrob Chemother; 1986 Jun; 17(6):747-53. PubMed ID: 3525497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of novel monobactams with activity against carbapenem-resistant Enterobacteriaceae - Identification of LYS228.
    Reck F; Bermingham A; Blais J; Capka V; Cariaga T; Casarez A; Colvin R; Dean CR; Fekete A; Gong W; Growcott E; Guo H; Jones AK; Li C; Li F; Lin X; Lindvall M; Lopez S; McKenney D; Metzger L; Moser HE; Prathapam R; Rasper D; Rudewicz P; Sethuraman V; Shen X; Shaul J; Simmons RL; Tashiro K; Tang D; Tjandra M; Turner N; Uehara T; Vitt C; Whitebread S; Yifru A; Zang X; Zhu Q
    Bioorg Med Chem Lett; 2018 Feb; 28(4):748-755. PubMed ID: 29336873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity and beta-lactamase stability of a monobactam, SQ 26,917, compared with those of aztreonam and other agents.
    Neu HC; Labthavikul P
    Antimicrob Agents Chemother; 1983 Aug; 24(2):227-32. PubMed ID: 6605715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vitro antibacterial activity of a new series of monobactam derivatives.
    Valcavi U; Aveta R; Brandt A; Corsi GB; Bosone E; Farina P; Guazzi G
    Farmaco Sci; 1988 Jun; 43(6):559-66. PubMed ID: 3208898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and development of the monobactams.
    Sykes RB; Bonner DP
    Rev Infect Dis; 1985; 7 Suppl 4():S579-93. PubMed ID: 3909315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of azthreonam and related monobactams with beta-lactamases from gram-negative bacteria.
    Bush K; Freudenberger JS; Sykes RB
    Antimicrob Agents Chemother; 1982 Sep; 22(3):414-20. PubMed ID: 6982680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active-Site Protonation States in an Acyl-Enzyme Intermediate of a Class A β-Lactamase with a Monobactam Substrate.
    Vandavasi VG; Langan PS; Weiss KL; Parks JM; Cooper JB; Ginell SL; Coates L
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antibacterial evaluation against resistant Gram-negative bacteria of monobactams bearing various substituents on oxime residue.
    Li ZW; Lu X; Wang YX; Hu XX; Fu HG; Gao LM; You XF; Tang S; Song DQ
    Bioorg Chem; 2020 Jan; 94():103487. PubMed ID: 31831161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antibacterial evaluation of new monobactams.
    Thu ZM; Sun J; Ji J; He L; Ji J; Iqbal Z; Myo KK; Gao Y; Zhai L; Mu Y; Tang D; Vidari G; Yang H; Yang Z
    Bioorg Med Chem Lett; 2021 May; 39():127878. PubMed ID: 33636305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro activity of tigemonam, an oral monobactam, against gram-negative rods, including variants in beta-lactamase-production.
    Brown J; Yang YJ; Livermore DM
    J Antimicrob Chemother; 1989 Feb; 23(2):201-7. PubMed ID: 2785102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The new monobactams: chemistry and biology.
    Sykes RB; Koster WH; Bonner DP
    J Clin Pharmacol; 1988 Feb; 28(2):113-9. PubMed ID: 3360965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antimicrobial properties of substituted 3-aminoxypropionyl and 3-aminoxy-(E)-2-methoxyiminopropionyl monobactams.
    Balsamo A; Macchia B; Orlandini E; Rossello A; Macchia F; Broccali G; Fonio W
    Farmaco; 1990 Jul; 45(7-8):879-88. PubMed ID: 2282121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of C(4) substituted monobactams as antibacterial agents against multidrug-resistant Gram-negative bacteria.
    Kou Q; Wang T; Zou F; Zhang S; Chen Q; Yang Y
    Eur J Med Chem; 2018 May; 151():98-109. PubMed ID: 29605810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basic design of beta-lactam antibiotics: penams and analogues and monocyclic beta-lactams.
    Ekström B
    Scand J Infect Dis Suppl; 1984; 42():38-49. PubMed ID: 6335599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in-vitro activity of SQ 82,291, a new monobactam, in comparison with aztreonam.
    García-Rodríguez JA; García-Sánchez JE; Plata A; Trujillano I
    J Antimicrob Chemother; 1986 Mar; 17(3):303-7. PubMed ID: 3754552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and reactivity with beta-lactamases of a monobactam bearing a retro-amide side chain.
    Adediran SA; Lohier JF; Cabaret D; Wakselman M; Pratt RF
    Bioorg Med Chem Lett; 2006 Feb; 16(4):869-71. PubMed ID: 16300942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.